The Prenylflavonoid Xanthohumol Reduces Alzheimer-Like Changes and Modulates Multiple Pathogenic Molecular Pathways in the Neuro2a/APPswe Cell Model of AD
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2018.00199
Full Text
Open PDFAbstract
Available in full text
Categories
Date
April 4, 2018
Authors
Publisher
Frontiers Media SA